Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02780336 · ClinicalTrials.gov registry record
Blepharospasm Tools
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 405
- Enrollment target
NCT02780336: Completed study, sponsored by Emory University.
NCT02780336 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 405 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02780336 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 405 participants
- Enrollment target
Study Summary
The aim of this study is to develop new rating scales to help diagnose and measure the severity of blepharospasm. This is a condition involving a lot of blinking and spasms of eye closure that people can't control. This study will also test some video software to see if it can help diagnose people or tell the severity of disease using only a video recording of an exam. There is an additional plan to create an educational video to teach others the proper use of the scale and video software.
Primary Outcome
The ratings for the BDRS will be examined for internal consistency by pair-wise correlations among all items in the scale in all combinations of possible pairs.
Interventions
- OTHER No intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 405 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-03-20 |
What the finished NCT02780336 record still lists
NCT02780336 is an observational study that tracks outcomes without assigning an intervention. The registered 405 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention. is the first listed.
NCT02780336 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02780336 about?
NCT02780336 is a clinical study titled "Blepharospasm Tools". The aim of this study is to develop new rating scales to help diagnose and measure the severity of blepharospasm. This is a condition involving a lot of blinking and spasms of eye closure that people can't control. This study will also test some video software to see if it can help diagnose people o...
What is the current status of trial NCT02780336?
This trial is currently completed. The enrollment target is 405 participants. The study started on 2016-08. Estimated completion is 2019-03-20.
What interventions are being tested in trial NCT02780336?
The interventions under investigation include: No intervention. (OTHER).
Who is sponsoring clinical trial NCT02780336?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05576350 · 405 participants · NA
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
- NCT07066657 · 405 participants · Phase 1
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- NCT06223360 · 406 participants · Phase 2
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- NCT06411769 · 406 participants · NA
Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia